The Burden of Multiple Myeloma

Thanks for joining the march!

Latest newsletter

Read our latest update: the April 2019 newsletter

Latest News

Lenalidomide-related Progressive Multifocal Leukoencephalopathy: A Case Report and Review of Drug-related Cases in Multiple Myeloma

Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system caused by reactivation of John Cunningham...
Continue Reading

Improved Clinical Outcomes in Relapsed/Refractory Multiple Myeloma With Daratumumab Re-Treatment

This story was originally published on the Hematology Advisor The introduction of monoclonal antibodies and immunomodulators into earlier lines of...
Continue Reading

New medicine for multiple myeloma shows promising results

A new drug reduced the risk of relapse and increased survival by five months, according to a recent study. The...
Continue Reading

New Zealand falling behind rest of world in cancer treatment, according to new myeloma report

Originally published on Health Industry Hub The management of New Zealand’s most common blood cancer, myeloma, is falling behind the...
Continue Reading

New Zealand lacks treatment access to myeloma patients – Myeloma New Zealand

This story was originally published on RNZ  An advocate group is warning that New Zealanders are dying from a common blood...
Continue Reading

NZ falling behind rest of world in cancer treatment – Myeloma NZ

The management of New Zealand’s most common blood cancer, myeloma, is falling behind the rest of the world, putting lives...
Continue Reading

Subscribe

Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.

Videos